Changzhou Yuanda Pharmaceutical Chemical Co., Ltd. is a high-tech company engaged in the operation of pharmaceutical chemical raw materials and the research, development, production, and operation of pharmaceutical active ingredients. Adhering to a product development philosophy of "high technology, high starting point, and high efficiency," the company aims to build a world-class high-tech enterprise integrating scientific research and production. With a corporate mission of "truth-seeking, pragmatism, innovation, and progress," it seizes opportunities, prioritizes people, upholds integrity and pragmatism, respects science, encourages innovation, promotes teamwork, expands international exchanges and cooperation, and establishes strategic alliances with the business community to achieve leapfrog development.

Changzhou Yuanda Pharmaceutical Chemical is committed to establishing a comprehensive mechanism integrating production, sales, and research. After a decade of pilot-scale amplification of new products, the company has accumulated extensive experience and developed a relatively complete technological innovation and development system. It is capable of conducting research, development, pilot-scale testing, and production of chemical reactions under special conditions such as high pressure, low temperature, high temperature, anhydrous, oxygen-free, and high vacuum. The company primarily focuses on drugs with high synthesis complexity, especially cardiovascular and cerebrovascular drugs, anticancer drugs, Alzheimer's disease medications, and psychiatric drugs. It researches, produces, and sells over forty high-end pharmaceutical active ingredients and key intermediates, while also providing comprehensive services including professional synthesis technology, analytical testing, patent affairs, regulatory registration, impurities, and reference standards. By highly integrating market-oriented technological research and engineering capabilities, the company accelerates the development and incubation of products and process technologies with independent intellectual property rights. It hopes to establish strategic alliances and production-operation joint ventures with domestic and international enterprises.